A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.
Saved in:
| Title: | A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. |
|---|---|
| Authors: | Richert, Iseulys1 (AUTHOR) paul.berchard@lyon.unicancer.fr, Berchard, Paul1 (AUTHOR) lhorra.abbes@lyon.unicancer.fr, Abbes, Lhorra1 (AUTHOR) jean-yves.blay@lyon.unicancer.fr, Novikov, Alexey2 (AUTHOR) an@hephaistos-pharma.com, Chettab, Kamel3,4 (AUTHOR) abdelkamel.chettab@univ-lyon1.fr, Vandermoeten, Alexandra5 (AUTHOR) alexandra.vandermoeten@univ-lyon1.fr, Dumontet, Charles3,4 (AUTHOR) charles.dumontet2@univ-lyon1.fr, Karanian, Marie6 (AUTHOR) marie.karanian@lyon.unicancer.fr, Kerzerho, Jerome2 (AUTHOR) jk@hephaistos-pharma.com, Caroff, Martine2 (AUTHOR) mc@hephaistos-pharma.com, Blay, Jean-Yves1,7,8 (AUTHOR), Dutour, Aurélie1 (AUTHOR) aurelie.dutour@lyon.unicancer.fr |
| Source: | Cancers. Sep2023, Vol. 15 Issue 18, p4635. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 172419419 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Richert%2C+Iseulys%22">Richert, Iseulys</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> paul.berchard@lyon.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Berchard%2C+Paul%22">Berchard, Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> lhorra.abbes@lyon.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Abbes%2C+Lhorra%22">Abbes, Lhorra</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jean-yves.blay@lyon.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Novikov%2C+Alexey%22">Novikov, Alexey</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> an@hephaistos-pharma.com</i><br /><searchLink fieldCode="AR" term="%22Chettab%2C+Kamel%22">Chettab, Kamel</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> abdelkamel.chettab@univ-lyon1.fr</i><br /><searchLink fieldCode="AR" term="%22Vandermoeten%2C+Alexandra%22">Vandermoeten, Alexandra</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> alexandra.vandermoeten@univ-lyon1.fr</i><br /><searchLink fieldCode="AR" term="%22Dumontet%2C+Charles%22">Dumontet, Charles</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> charles.dumontet2@univ-lyon1.fr</i><br /><searchLink fieldCode="AR" term="%22Karanian%2C+Marie%22">Karanian, Marie</searchLink><relatesTo>6</relatesTo> (AUTHOR)<i> marie.karanian@lyon.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Kerzerho%2C+Jerome%22">Kerzerho, Jerome</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> jk@hephaistos-pharma.com</i><br /><searchLink fieldCode="AR" term="%22Caroff%2C+Martine%22">Caroff, Martine</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> mc@hephaistos-pharma.com</i><br /><searchLink fieldCode="AR" term="%22Blay%2C+Jean-Yves%22">Blay, Jean-Yves</searchLink><relatesTo>1,7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dutour%2C+Aurélie%22">Dutour, Aurélie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> aurelie.dutour@lyon.unicancer.fr</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Sep2023, Vol. 15 Issue 18, p4635. 24p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=172419419 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers15184635 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 24 StartPage: 4635 Titles: – TitleFull: A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Richert, Iseulys – PersonEntity: Name: NameFull: Berchard, Paul – PersonEntity: Name: NameFull: Abbes, Lhorra – PersonEntity: Name: NameFull: Novikov, Alexey – PersonEntity: Name: NameFull: Chettab, Kamel – PersonEntity: Name: NameFull: Vandermoeten, Alexandra – PersonEntity: Name: NameFull: Dumontet, Charles – PersonEntity: Name: NameFull: Karanian, Marie – PersonEntity: Name: NameFull: Kerzerho, Jerome – PersonEntity: Name: NameFull: Caroff, Martine – PersonEntity: Name: NameFull: Blay, Jean-Yves – PersonEntity: Name: NameFull: Dutour, Aurélie IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: Sep2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 20726694 Numbering: – Type: volume Value: 15 – Type: issue Value: 18 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |